NCT06077240 Effects of E-cigs vs Pouches on Cigarette Smoking and Addiction
| NCT ID | NCT06077240 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yale University |
| Condition | Smoking |
| Study Type | INTERVENTIONAL |
| Enrollment | 256 participants |
| Start Date | 2024-08-20 |
| Primary Completion | 2028-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 256 participants in total. It began in 2024-08-20 with a primary completion date of 2028-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study will recruit an anticipated 256 adults who currently smoke cigarettes and report a willingness to try switching to alternative, non-combustible products. Participants will be randomized to receive either e-cigarettes or nicotine pouches for a duration of 4 weeks and to 1 of 4 possible regulatory scenarios within products where flavor availability is either menthol and tobacco/unflavored available or tobacco/unflavored only available, and nicotine concentration is either higher (5% e-cig, 6mg pouch) or lower (2.4% e-cig, 3mg pouch). Participants will return for bi-weekly research visits (in person or remote videocall) to complete measures for study aims. Participants will complete a final follow-up at Week 6 to assess maintenance of cigarette reduction and willingness to continue using products once they are no longer provided. The investigators expect to observe which products and constituents lead to greater smoking reduction.
Eligibility Criteria
Inclusion Criteria: * 21+ years old * English literate * Currently smoking cigarettes, biochemically confirmed Exclusion Criteria: * Currently using smoking cessation pharmacotherapies (NRT, bupropion, varenicline) * Currently pregnant or breastfeeding * Significant current medical or psychiatric condition * Known hypersensitivity to propylene glycol
Contact & Investigator
Lisa Fucito, PhD
PRINCIPAL INVESTIGATOR
Yale University
Frequently Asked Questions
Who can join the NCT06077240 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, studying Smoking. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06077240 currently recruiting?
Yes, NCT06077240 is actively recruiting participants. Contact the research team at lisa.fucito@yale.edu for enrollment information.
Where is the NCT06077240 trial being conducted?
This trial is being conducted at New Haven, United States.
Who is sponsoring the NCT06077240 clinical trial?
NCT06077240 is sponsored by Yale University. The principal investigator is Lisa Fucito, PhD at Yale University. The trial plans to enroll 256 participants.